Table 2.
Abundance of IC Subtypes during Obstruction
| % of CD cells Total ICs | % of ICs (% of CD cells ± standard deviation)
|
||||
|---|---|---|---|---|---|
| Type A | Type B | Non-A non-B | Immature | ||
| 18 weeks | |||||
| Control | 3.9 ± 1.4 | 8.4 (0.3 ± 0.5) | 0 | 0 | 91.6 (3.5) |
| Obstructed | 6.0 ± 2.8 | 33.1 (2.0 ± 1.8) | 23 (1.4 ± 1.2) | 7.0 (0.4 ± 0.7) | 36.9 (2.2) |
| 36 weeks | |||||
| Control | 5.7 ± 2.7 | 92.9 (5.3 ± 2.8) | * | * | 7.1 (0.4) |
| Obstructed | 10.8 ± 6.2 | 68.8 (7.4 ± 6.0) | 5.1 (0.5 ± 0.9) | 7.1 (0.8 ± 1.0) | 19.0 (2.1) |
| 1 year postnatal | |||||
| Control | 10.7 ± 6.2 | 70.2 (7.5 ± 4.8) | 0 | 0 | 29.8 (3.2) |
| Obstructed | 3.8 ± 4.8 | 70.8 (2.7 ± 4.2) | 1.0 (0.04 ± 0.2) | 0 | 28.2 (1.1) |
ICs fractions expressed as percentage of CD cells ± standard deviation. Numbers in bold express IC subtypes as a percentage of total ICs. Immature cells are calculated as percent of total cells minus Type A, B and non-A non-B subtypes and therefore have no standard deviations.
*
Pendrin-positive cells not observed in 36-week gestation kidney.